GlassScriptPhysician profile
Geary D Bush
NPI 1447437082
$5,794.94
in general payments reported to CMS, 2019-2025
25 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $126 · 2021: $1,791 · 2022: $2,787 · 2023: $163 · 2024: $607 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Food and Beverage | $382.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,662.18 | 2019-2024 | |
| Baxter Healthcare | $185.15 | 2020-2021 | |
| Merit Medical Systems INC | $138.28 | 2022 | |
| Myriad Genetic Laboratories, INC. | $120.26 | 2021-2025 | Myrisk |
| Tela Bio, INC. | $79.47 | 2019 | |
| Molli Surgical (US) INC | $76.95 | 2023 | |
| Davol INC. | $71.54 | 2020-2025 | Arista |
| Medtronic, INC. | $67.87 | 2022-2023 | Nim Vital, Gi Genius |
| Mallinckrodt Enterprises LLC | $38.61 | 2019 | |
| Dilon Technologies, INC. | $38.02 | 2024 | Hemoblast Bellows |
| Allergan, INC. | $36.69 | 2020-2022 | |
| Braintree Laboratories, INC. | $34.33 | 2020-2025 | Sutab, Suflave |
| Integra Lifesciences Corporation | $27.71 | 2022 | |
| Heron Therapeutics, INC. | $26.73 | 2024 | Zynrelef |
| W. L. Gore & Associates, INC. | $26.42 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23.59 | 2024 | Menveo, Bexsero, Pediarix |
| Cardinal Health 414 LLC | $18.66 | 2024 | |
| Bard Peripheral Vascular, INC. | $18.20 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.93 | 2021 | |
| Acell, INC. | $16.63 | 2020 | |
| Elucent Medical | $16.26 | 2025 | |
| Ethicon US, LLC | $15.72 | 2019 | |
| Smith+Nephew, INC. | $14.47 | 2025 | Renasys Touch, Pico 14 |
| Focal Therapeutics, INC. | $13.26 | 2019 | |
| Axonics, INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geary Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.